Lila Kagit Sanayi Ve Ticaret Anonim Sirketi · BIST:LILAK
Lila Kagit Sanayi Ve Ticaret Anonim Sirketi — Lila Kağıt Sanayi ve Ticaret A.Ş. — Q3 2026 Earnings Presentation
16 slides from Lila Kagit Sanayi Ve Ticaret Anonim Sirketi's earnings presentation, Oct 27, 2026
Slide 1: 3Q 2026 Financial Results
3Q 2026 Financial Results October 27, 2026 3Q 2026 Financial Results
Slide 2: Legal Notice
Legal Notice Pursuant to the Capital Markets Board (CMB) Bulletin dated December 28, 2023, and numbered 2023/81, it was publicly announced that issuers and capital market institutions subject to the CMB’s financial reporting regulations are required to implement inflation accounting in accordance wi
Slide 3: 3Q 2026 Market and Company Overview
3Q 2026 Market and Company Overview Soft demand, intense price competition and rising costs weighed on industry profitability Industry and Market Dynamics Implications for Lila Kağıt • Global tissue paper demand remained restricted and varied • Lila Kağıt maintained total sales volume broadly in lin
Slide 4: 3Q 2026 Volumes Held Steady Amid Pricing and FX Pressure on Margins
3Q 2026 Volumes Held Steady Amid Pricing and FX Pressure on Margins Export performance supported operations, while geopolitical uncertainty, pricing and FX dynamics weighed on margins 3Q26 Operational Performance 3Q26 Financial Performance Sales Sales Volume Domestic Branded Net Sales EBITDA EBITDA
Slide 5: 3Q 2026 Operational Performance
3Q 2026 OPERATIONAL PERFORMANCE
Slide 6: We Continued to Maintain Our Strong Position in Export Markets
We Continued to Maintain Our Strong Position in Export Markets UNITED KINGDOM • Lila Kağıt accounted for 28%(2) of EUROPE Türkiye’s tissue paper exports in the first eight months of 2026. NORTH & SOUTH 43% 37% AMERICA 52% 38% ASIA • Exports represented 75%(2) of total 3Q 2025 3Q 2026 sales volume in
Slide 7: Strong Production Recovery and Above-Industry Capacity Utilization
Strong Production Recovery and Above -Industry Capacity Utilization Lila Kağıt’s capacity utilization rate increased by 1 percentage point year over year to 83% in 3Q26, 6 percentage points above the Turkish tissue paper industry average. In 9M26, Lila Kağıt’s capacity utilization reached 87%, excee
Slide 8: 3Q 2026 Financial Performance
3Q 2026 FINANCIAL PERFORMANCE
Slide 9: Pricing Pressure and the FX–Inflation Gap Constrained Profitability
Pricing Pressure and the FX –Inflation Gap Constrained Profitability Pressure on foreign currency selling prices, exchange rate increases below inflation and higher TRY -denominated operating expens es affected profit margins Gross Profit Margin EBITDA Margin Net Profit Margin 3Q 2026 23.6% (-786 bp
Slide 10: Pricing Pressure and TRY Cost Inflation Contracted EBITDA Margin
Pricing Pressure and TRY Cost Inflation Contracted EBITDA Margin Value Analysis of Net Sales (TL million) EBITDA Margin Bridge (%) 4,136 84 3,709 (407) (68) (35) 20.8% -786 bp -272 bp +65 bp 10.9% 3Q 2026 Price / Product Mix Volume Price / Product Mix Volume 3Q 2026 Q3 2025 Gross Margin OpEx D&A Exp
Slide 11: Working Capital Efficiency Supported Operational Cash Flows and Strong Balance Sheet
Working Capital Efficiency Supported Operational Cash Flows and Strong Balance Sheet Trade Receivables (Days) Inventories (Days) Strong Net Cash Position of Net Cash Bridge (TL million) Trade Payables (Days) Cash Conversion Cycle (Days) TRY 4.3 Billion 2,815 • The net cash position 122 was maintaine
Slide 12: Positive Free Cash Flow Maintained During Intensive Investment Period
Positive Free Cash Flow Mainta ined During Intensive Investment Period Cash Flow from Operations (TRY million) Erzurum Plant (1) Free Cash Flow (TRY million) Ergene Plant & Others Free Cash Flow / Net Sales CAPEX / Net Sales Total Capital Expenditures (TRY million) 18.2% 6.9% 6.6% 11.6% 1,541 2,815
Slide 13: 2026 Guidance
2026 GUIDANCE
Slide 14: 4Q26 Closing Outlook: Margin and Cash Discipline in a Weak Pricing Environment
4Q26 Closing Outlook: Margin and Cash Discipline in a Weak Pricing Environment Drivers Supporting Year -End Targets Key Risks • Our year-end outlook does not assume a broad -based market • Flat and regional ly divergent global tissue paper demand, together recovery. We expect export growth in the mi
Slide 15: We Revise Our 2026 Guidance
We Revise Our 2026 Guidance Initial Guidance Revise d Guidance C urrent Guidance Sales Volume Growth 7%-10% 7%-10% 1%-3% Domestic Market High double -digit growth Mid-to-high single -digit growth Flat Export Markets Low-to-mid single -digit growth High single -digit growth Mid-single -digit growth E
Slide 16: Thank You
Contact Işıl Tireli Doruk Sazer, CFA Şevval Hacer Şenol Deputy General Manager of Financial Head of Investor Relations Affairs, Strategic Planning and Investor Relations Specialist Information Technologies +90 (216) 251 27 00 +90 (216) 251 27 00 +90 (216) 251 27 00 www.lilakagit.com yatirimciiliskil
Lila Kağıt Sanayi ve Ticaret A.Ş. — Q3 2026 Earnings Presentation on 6ix